News
Venture capital companies remained the most active space investors in recent months, contributing 77% of 2025 funding in the ...
NASA officials remain eager for Starliner to begin these regular crew rotation flights, even as its sole destination, the ISS ...
Rooted in Varda’s early photography, the Musée Carnavalet’s show illuminates and clarifies the singular nature of a great ...
The SpaceX program is still in the early stages of development and the plans could change. The effort is highly reliant on ...
The funds will be used to improve the company's flight cadence and expand its pharmaceutical lab capabilities.
Varda Space Industries, which is leveraging reusable rockets to manufacture drugs in low Earth orbit, has received more fuel for its endeavors in the form of a $187 million series C fundraising haul.
Varda Space Industries has secured $187 million from investors, including Natural Capital and Shrug Capital, to advance its ...
Varda Space Industries secures $187 million in funding to advance its groundbreaking technology for drug manufacturing in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results